Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

Recruiting

Conditions: Bilateral Vocal Cord Paralysis

First Posted Date: 2019-06-10

Last Posted Date: 2025-05-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT03980275

Locations: 🇺🇸
Sean Parker Institute for the Voice, New York, New York, United States

GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Not Applicable

Withdrawn

Conditions: Psychological Feedback
Cancer
Liquid Tumor

Interventions: Behavioral: GIST

First Posted Date: 2019-05-22

Last Posted Date: 2024-02-15

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03959046

Locations: 🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Effect of Lifitegrast 5% on Tear Film Markers

Phase 4

Withdrawn

Conditions: Dry Eye Syndromes
Dry Eyes Chronic
Dry Eye

Interventions: Drug: Lifitegrast 5% Ophthalmic Solution

First Posted Date: 2019-05-16

Last Posted Date: 2021-02-16

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03952481

Locations: 🇺🇸
Weill Cornell Ophthalmology, New York, New York, United States

Individualizing Antidepressant Treatment Using Pharmacogenomics and EHR-driven Clinical Decision Support

Not Applicable

Withdrawn

Conditions: Depression

Interventions: Genetic: Genomind®Professional PGx Express TM

First Posted Date: 2019-05-16

Last Posted Date: 2021-11-08

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03952494

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas

Phase 2

Terminated

Conditions: Recurrent Pituitary Adenomas

Interventions: Drug: Capecitabine
Drug: Temozolomide

First Posted Date: 2019-04-29

Last Posted Date: 2022-08-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT03930771

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Completed

Conditions: Renal Insufficiency, Chronic
Diabetes Mellitus, Type 2

Interventions: Drug: Sulfonylurea
Drug: DPP-4 inhibitor
Drug: SGLT2 inhibitor
Drug: GLP1 receptor agonist
Drug: Metformin

First Posted Date: 2019-04-19

Last Posted Date: 2023-11-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4888

Registration Number: NCT03921242

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Phase 2

Completed

Conditions: Esophagogastric Adenocarcinoma

Interventions: Drug: Telomelysin

First Posted Date: 2019-04-19

Last Posted Date: 2024-06-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 17

Registration Number: NCT03921021

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Weill Cornell Medical College, New York, New York, United States

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Conditions: Autosomal Dominant Polycystic Kidney Disease

First Posted Date: 2019-04-03

Last Posted Date: 2025-02-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 100

Registration Number: NCT03901521

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Study of the Food Order Behavioral Intervention in Prediabetes

Not Applicable

Completed

Conditions: Pre Diabetes
Obesity

Interventions: Behavioral: Food order behavioral intervention plus standard care
Behavioral: Standard Care

First Posted Date: 2019-03-29

Last Posted Date: 2022-02-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 79

Registration Number: NCT03896360

Locations: 🇺🇸
Comprehensive Weight Control Center, New York, New York, United States

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

Active, not recruiting

Conditions: Kidney Diseases
Dyslipidemias
Cardiac Death
Diabetes
Obesity
Smoking
Physical Inactivity
Inflammation
Stroke
Hypertension

First Posted Date: 2019-03-27

Last Posted Date: 2025-03-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 3005

Registration Number: NCT03892265

Locations: 🇭🇹
Les Centres GHESKIO, Port-au-Prince, West, Haiti

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy